A new systematic literature review has found that it may not be cost-effective to provide primary screening for chronic kidney disease (CKD) in the general population.
However, primary CKD prevention screening does appear to be cost-effective in patients with diabetes and hypertension.
John Schieszer has the latest on the story in today’s Medical Minute.
Next post in The Medical Minute
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.